- Home
- TARA vs SPCE Comparison
TARA vs SPCE Comparison
Compare TARA & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | SPCE |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 287.2M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TARA | SPCE |
|---|---|---|
| Price | $4.41 | $4.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $24.40 | $3.06 |
| AVG Volume (30 Days) | 722.6K | ★ 41.6M |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.25 | ★ 60.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,948,000.00 | $1,544,000.00 |
| Revenue This Year | N/A | $2,270.73 |
| Revenue Next Year | N/A | $880.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $2.13 |
| 52 Week High | $7.82 | $8.90 |
Technical Indicators
Market Signals| Indicator | TARA | SPCE |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 58.15 |
| Support Level | $4.21 | $2.74 |
| Resistance Level | $4.59 | N/A |
| Average True Range (ATR) | 0.28 | 0.98 |
| MACD | -0.05 | 0.18 |
| Stochastic Oscillator | 19.61 | 38.69 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.